UOC
CVRS

UBS O'Connor’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

UBS O'Connor’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-143,940
Closed -$444K – 601
2015
Q3 		$444K Sell
143,940
-70,860
-33% -$256K ﹤0.01% 466
2015
Q2 		$754K Buy
+214,800
New +$916K 0.01% 643

Other funds holding CVRS

HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.31B AUM 35.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS O'Connor's CVRS Position: Q4 2015 in Review

UBS O'Connor sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2015, closing a stake of 143,940 shares — an estimated $444K sold.

UBS O'Connor first reported a position in CVRS in Q2 2015 and held it in 2 quarters. The position peaked at $754K in Q2 2015. 35 funds tracked by Wall St. Rank hold CVRS as of Q4 2015.

  • UBS O'Connor reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2015 after selling out during the quarter.
  • UBS O'Connor sold 143,940 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2015, an estimated $444K.
  • UBS O'Connor first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 2 quarters.
  • UBS O'Connor's CORINDUS VASCULAR ROBOTICS, INC position peaked at $754K in Q2 2015.
  • 35 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2015.

Based on UBS O'Connor's 13F filing for Q4 2015, filed 10 Feb 2016.